Skip to Content

OraVerse Approval History

  • FDA approved: Yes (First approved May 9th, 2008)
  • Brand name: OraVerse
  • Generic name: phentolamine mesylate
  • Dosage form: Injection
  • Company: Novalar Pharmaceuticals, Inc.
  • Treatment for: Reversal of Anesthesia

OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Development History and FDA Approval Process for OraVerse

May 12, 2008Approval Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.